The
Protein Sequencing Market is transforming the field of molecular biology and biomedicine, offering powerful tools to unravel the complexities of proteins. Protein sequencing, which involves determining the amino acid sequence of proteins, plays a vital role in drug discovery, biomarker identification, and precision medicine. This market is growing rapidly due to advancements in next-generation sequencing technologies and increasing investments in proteomics research. The Protein Sequencing Market is paving the way for groundbreaking innovations in science and healthcare.
Global Protein Sequencing Market Overview
The global protein sequencing market is driven by the increasing demand for advanced proteomics tools in research and clinical diagnostics. High-throughput sequencing technologies, combined with data analytics, are enhancing the accuracy and speed of protein sequencing. According to BIS Research, the market was valued at $1,749.0 million in 2023 and is projected to reach $2,697.0 million by 2033, growing at a CAGR of 4.36% during the forecast period of 2024-2033. This growth is fueled by the rising focus on personalized medicine and the growing need to understand protein functions and interactions.
Global Protein Sequencing Market Segmentation
Segmentation 1: based on Product and Service
• Product
• Service
Segmentation 2: based on Application
• Biotherapeutics
• Genetic Engineering
• Others
Segmentation 3: based on Sample Type
• Biological Sample
• Tissue Sample
• Cultured Cell
• Other Samples
Segmentation 4: based on Technology
• Mass Spectrometry
• Edman Degradation
• Other Technologies
Segmentation 5: based on End User
• Academic Institutes
• Pharma and CROs
• Biotech, Diagnostics, and Other Companies
Segmentation 6: based on Region
• North America
o U.S.
o Canada
• Europe
o Germany
o U.K.
o France
o Italy
o Spain
o Rest-of-Europe
• Asia-Pacific
o China
o Japan
o India
o Australia
o South Korea
o Rest-of-Asia-Pacific
• Latin America
o Brazil
o Mexico
o Rest-of-Latin America
• Rest-of-the-World
Key Market Players
Some prominent names established in this market are:
• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific, Inc.
• Shimadzu Corporation
• Charles River Laboratories
• Selvita
• Bruker Corporation
• Merck KGaA
• Seer, Inc.
• FUJIFILM Holdings Corporation
Global Protein Sequencing Market Demand – Drivers and Challenges
Market Demand Drivers:
The protein sequencing market is advancing rapidly, fueled by innovations in computational biology and bioinformatics. These technologies are critical in areas like drug discovery, proteomics research, and biomarker development. By employing advanced algorithms and extensive biological data, they refine protein sequence analysis and design, improving the precision and effectiveness of sequencing techniques.
Market Challenges:
A shortage of qualified professionals presents a major obstacle for the protein sequencing market. The process demands in-depth knowledge of biochemistry, molecular biology, and specialized analytical methods. Expertise is required to operate high-precision instruments such as mass spectrometers and to handle the complex computational tasks involved in processing and interpreting large-scale sequencing data.
Market Opportunities:
Artificial intelligence is creating promising prospects in protein sequencing. Machine learning applications, paired with cutting-edge materials like solid-state 2D phosphorene nanoslit devices, are driving innovation in molecular diagnostics. These advancements are enabling rapid and highly accurate amino acid identification at the single-molecule level, overcoming challenges associated with high-throughput sequencing and paving the way for improved therapeutic solutions.
According to Swati Sood, Principal Analyst – BIS Research, “The protein sequencing market is poised for robust growth, driven by technological advancements, decreasing costs, and expanding clinical applications in precision medicine and diagnostics. Analysts anticipate significant opportunities for innovation and investment across healthcare, pharmaceuticals, and biotechnology sectors, leading to improved patient outcomes and accelerated drug development.”
Explore BIS Research’s tailored
Go-to-Market Strategy that help businesses explore and enter emerging markets, promising professional guidance to unlock new opportunities.
